Defective acute inflammation in Crohn's disease: a clinical investigation

@article{Marks2006DefectiveAI,
  title={Defective acute inflammation in Crohn's disease: a clinical investigation},
  author={Daniel Marks and Marcus Wn Harbord and Raymond J Macallister and Farooq Z Rahman and Jodi Young and Bissan Al-Lazikani and William D. Lees and Marco Novelli and Stuart L Bloom and Anthony Walter Segal},
  journal={The Lancet},
  year={2006},
  volume={367},
  pages={668-678}
}

Figures from this paper

Crohn’s disease is caused by a failure of the innate immune response with major abnormalities in macrophage biology
  • A. Segal
  • Medicine
    Journal of Translational Medicine
  • 2010
TLDR
These studies demonstrated that Crohn’s patients possess a constitutionally weak innate immune response that leads to impaired removal of intestinal contents that breach the mucosal barrier of the bowel wall, resulting in granuloma formation and chronic inflammation.
An investigation of molecular defects underlying impaired acute inflammation in Crohn’s disease
TLDR
A role for immune deficiency in the pathogenesis of CD is supported and abnormal optineurin expression is identified as a relevant molecular abnormality in a subset of patients.
Disruption of macrophage pro-inflammatory cytokine release in Crohn's disease is associated with reduced optineurin expression in a subset of patients
TLDR
Identifying and studying subgroups of patients with shared defective gene expression could aid the understanding of the mechanisms underlying highly heterogeneous diseases such as Crohn's disease.
Defective innate immunity in inflammatory bowel disease: a Crohn's disease exclusivity?
  • D. Marks
  • Medicine, Biology
    Current opinion in gastroenterology
  • 2011
TLDR
The demonstration of impaired acute inflammation in Crohn's disease provides a novel mechanism for its pathogenesis, with diminished macrophage cytokine production and neutrophil recruitment leading to reduced bacterial clearance.
LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease
TLDR
It is suggested that genetically determined levels of these cytokines obtained from LPS-stimulated whole blood cultures are not linked with disease behavior or severity.
Studies on patients establish Crohn's disease as a manifestation of impaired innate immunity
  • A. Segal
  • Medicine, Biology
    Journal of internal medicine
  • 2019
TLDR
Evidence is provided, obtained from patients with this condition, that the common predisposition to Crohn's is a failure of the acute inflammatory response to tissue damage, which leads to a chronic granulomatous inflammation.
What Is Wrong with Granulocytes in Inflammatory Bowel Diseases?
TLDR
Stimulation of the innate immune system in CD, particularly in patients in remission, may be an alternative therapeutic strategy that could reduce the risk of future disease relapses.
Innate immunity in inflammatory bowel disease: a disease hypothesis
TLDR
Rather than Crohn's disease being caused by excessive inflammation, the primary mechanism is actually that of an immunodeficiency, which can be compensated in some circumstances by signalling through NOD2.
Defective IL‐10 production in severe phenotypes of Crohn's disease
TLDR
A defect in IL‐10 production is shown in whole blood cell cultures and MDDCs in patients with severe forms of Crohn's disease, which may represent a mechanism mediating more severe manifestations of the disease.
Peripheral Monocyte Functions and Activation in Patients with Quiescent Crohn’s Disease
TLDR
It is highlighted that defective innate immune mechanisms in CD seems to play a role in the (inflamed) intestinal mucosa rather than in peripheral blood, and peripheral blood monocytes from CD patients in clinical remission were not impaired compared to healthy controls.
...
...

References

SHOWING 1-10 OF 64 REFERENCES
Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn’s disease
TLDR
Elevated proinflammatory cytokine transcripts in active CD may underlie disease reactivation and chronicity and may be useful in identifying patients who would benefit from anti-inflammatory remission maintenance.
Defects in mucosal immunity leading to Crohn's disease
TLDR
Crohn's disease is characterized by patchy transmural inflammation involving any part of the intestinal tract, and one may consider a model in which defective innate immune clearance of pathogens or commensal bacteria in CD leads to an inappropriate adaptive immune response to thecommensal flora.
The immunological and genetic basis of inflammatory bowel disease
TLDR
The most important finding is the identification of mutations in the gene that encodes NOD2 (nucleotide-binding oligomerization domain 2) protein in a subgroup of patients with Crohn's disease.
A Polymorphism in the CD14 Gene is Associated with Crohn Disease
TLDR
An altered immune response to LPS seems to play a role in the genetic predisposition to CD but not to UC, and T allele and TT genotype frequencies were found increased in CD patients compared to controls.
The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease.
TLDR
Smokers with IBD had a significant reduction in cytokine levels; specifically, IL-1beta and IL-8 for patients with UC and IL -8 for Patients with CD, and further studies are warranted to determine if this reduction in inflammation levels is histologically and clinically significant.
Role of C5a in inflammatory responses.
TLDR
Accumulating data suggest that C5a provides a vital bridge between innate and adaptive immune functions, extending the roles of C5o in inflammation.
Helminths as therapeutic agents for inflammatory bowel disease
TLDR
This review and critique the data in support of helminth therapy for inflammatory bowel disease draws attention to the gaps in knowledge and presents a view on how the field may be advanced.
Review article: helminths as therapeutic agents for inflammatory bowel disease.
TLDR
This review and critique the data in support of helminth therapy for inflammatory bowel disease draws attention to the gaps in knowledge and presents a view on how the field may be advanced.
...
...